about
Hypothalamic involvement in chronic migraineApplication of ICHD-II criteria in a headache clinic of China.Classification and clinical features of headache disorders in Pakistan: a retrospective review of clinical data.Botulinum toxin A for chronic daily headache: a randomized, placebo-controlled, parallel design study.Hemicrania continua with aura.New appendix criteria open for a broader concept of chronic migraine.Shared mechanisms and comorbidities in neurologic and psychiatric disorders.The prophylactic treatment of chronic daily headache.Analysis of the patients attending a specialist UK headache clinic over a 3-year period.Are investigations anxiolytic or anxiogenic? A randomised controlled trial of neuroimaging to provide reassurance in chronic daily headacheChronic migraine classification: current knowledge and future perspectivesPreventive treatment of migraine: effect on weight.Management of chronic daily headache: challenges in clinical practice.Chronic migraine and medication-overuse headache through the ages.Headache associated with pituitary tumors.Botulinum toxin type A for the treatment of migraine.Pharmacogenetics of migraine: genetic variants and their potential role in migraine therapy.Epidemiological profiles of patients with chronic migraine and chronic tension-type headacheIs there hope for chronic pain and headache?Elevated blood pressure and analgesic overuse in chronic daily headache: an outpatient clinic-based study from ChinaAssociation of psychiatric co-morbidity and efficacy of treatment in chronic daily headache in Indian population.Prevalence of primary headache disorders in a population aged 60 years and older in a rural area of Northern ChinaReview of botulinum toxin type A for the prophylactic treatment of chronic daily headache.Predictors of outcome of the treatment programme in a multidisciplinary headache centre.A redefinition of primary headache: chronic migraine.Emerging treatment for chronic migraine and refractory chronic migraine.Psychiatric comorbidity of chronic daily headache: focus on traumatic experiences in childhood, post-traumatic stress disorder and suicidality.Outcome of Chronic Daily Headache or Chronic Migraine.Placebo response in a patient with chronic migraine and ergotic overuse.Botulinum Toxin Type A in the treatment of chronic migraine without medication overuse.Cortical inhibition is reduced in chronic and episodic migraine and demonstrates a spectrum of illness.Onabotulinum toxin A in the treatment of chronic migraine: patient selection and special considerations.Disability in chronic migraine with medication overuse: treatment effects through 5 years.Botulinum toxin type a for the prophylaxis of chronic daily headache: subgroup analysis of patients not receiving other prophylactic medications: a randomized double-blind, placebo-controlled study.Intravenous valproate sodium in the treatment of daily headache.Primary headaches in an outpatient neurology headache clinic in East Hungary.Intravenous lignocaine (lidocaine) infusion for the treatment of chronic daily headache with substantial medication overuse.Cerebrospinal fluid glutamate levels in chronic migraine.Botulinum toxin type A (BOTOX) for the prophylactic treatment of chronic daily headache: a randomized, double-blind, placebo-controlled trial.Botulinum toxin injections for headache.
P2860
Q28365259-14AE309D-5936-42CA-92DC-4D971B7DB3A6Q31109157-09FA98A7-E6F1-4240-AB28-22EACA2DAD8FQ33463356-24B768AB-3731-47FD-90C3-6A773BD0F3C0Q33974749-FC1160CD-30FD-4390-9705-770C83D8D4B7Q34131630-9CE34235-C9D2-47A6-8F34-052A768982D2Q34523930-AB6F5721-313C-4A84-A138-B21B8A3331B9Q34570661-969A5BF8-E7B1-44C0-A255-9D06C388A84FQ34583067-14964E09-AE4D-4013-85EB-02148338A3BBQ35178624-CBF29414-2EFB-488B-9A23-279C6049191CQ35484728-ED9611BB-8927-42D2-8FE8-8ABD2D6C836BQ35522685-B06C7346-8312-45E5-A91C-E10131EE0DBAQ35987931-7127FCCE-99EC-4F2E-BEB8-CF80B089213BQ36099528-001A7096-3208-4895-A11D-778437A8C377Q36102253-96949CC5-6C62-47C8-8E45-70F053310AA6Q36259849-40636C00-573B-4C58-82A0-72A6F1534D23Q36488226-1E5DB076-996B-4027-AC41-DF089600DE80Q36845122-50959EB2-4259-425D-9434-FC733F737279Q36847280-48D1BA21-CCA8-4326-83AB-CD8BC29A624EQ36947170-6F2913E0-C737-4841-9B65-8322A5EE73A5Q36952569-B490AE10-BAB8-4642-893F-63EEDDF07D31Q37047332-D564E18E-096A-458A-A1E9-8D8233176FBDQ37250228-7C29D963-33DC-4E12-AD45-226B1DE62581Q37418971-9F2498C5-B58B-4C07-AD67-050987412D72Q37790517-84484A41-CEB1-409E-A6CE-35E4A9F75E93Q38014278-870C8CDB-0BD4-460F-B257-3FF67795E9FBQ38031982-4F0D4DA6-ED5C-486E-B550-91985C2AA5C9Q38188489-C5223666-9C45-4D63-8A50-A77811F4670EQ38676484-0A1E2A7B-B3FE-45D8-BCA0-3FE6B0D5873EQ39368081-C054AD4B-2EC6-4931-AEED-7F28F41956C0Q39823490-4D07AAAA-17D1-4D41-9011-F266B050A834Q40414417-0CB4B8EB-6533-43CC-8769-C7F05BA7CF52Q42370565-13AE3221-8955-40D2-ADCA-1A33ECB38E14Q42627933-ED43D8FE-0353-44CC-9176-8AFDEA07658BQ42653763-936968B8-509B-4A95-94E3-BEB0C8B5AD36Q44093894-9C32178B-7FBE-4665-BCD5-FC51C8E9610CQ44269757-4F74A7E9-8A4F-492F-A93B-BC80CFB89C0EQ44776564-34352BBF-7C98-47C0-8547-E704910E42E4Q45021407-F469321B-E245-4E07-95A5-9ED638AE2916Q46442389-5C1F289C-74A8-4B45-8B4C-7FE403E8B900Q46505020-EAE4EFDA-58DC-44D7-ACE0-93234307E89D
P2860
description
2000 nî lūn-bûn
@nan
2000 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2000 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2000年の論文
@ja
2000年論文
@yue
2000年論文
@zh-hant
2000年論文
@zh-hk
2000年論文
@zh-mo
2000年論文
@zh-tw
2000年论文
@wuu
name
Chronic daily headache.
@ast
Chronic daily headache.
@en
Kronisk daglig hodepine
@nb
type
label
Chronic daily headache.
@ast
Chronic daily headache.
@en
Kronisk daglig hodepine
@nb
prefLabel
Chronic daily headache.
@ast
Chronic daily headache.
@en
Kronisk daglig hodepine
@nb
P1476
Chronic daily headache.
@en
P2093
Silberstein SD
P304
P356
10.1097/00019052-200006000-00008
P577
2000-06-01T00:00:00Z